Drug repurposing screens to identify potential drugs for chronic kidney disease by targeting prostaglandin E2 receptor

Renal inflammation and fibrosis are significantly correlated with the deterioration of kidney function and result in chronic kidney disease (CKD). However, current therapies only delay disease progression and have limited treatment effects. Hence, the development of innovative therapeutic approaches...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Hung-Jin, Lee, Yu-Hsuan, Sung, Li-Chin, Chen, Yi-Jie, Chiu, Yu-Jhe, Chiu, Hui-Wen, Zheng, Cai-Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362296/
https://www.ncbi.nlm.nih.gov/pubmed/37484490
http://dx.doi.org/10.1016/j.csbj.2023.07.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362296/
https://www.ncbi.nlm.nih.gov/pubmed/37484490
http://dx.doi.org/10.1016/j.csbj.2023.07.007

Ejemplares similares